BridgeMD
New treatment option for Retroperitoneal Sarcoma
Official title Proton or Photon RT for Retroperitoneal Sarcomas
ClinicalTrials.gov ID: NCT01659203
What this study is testing
- What it's testing
- This research study is a Phase I clinical trial. Phase I clinical trials test the safety of an investigational intervention.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Histologically proven primary soft tissue sarcoma of the retroperitoneum
- Measurable disease
- Life expectancy of greater than 2 years
You likely can't join if
- Prior radiation therapy for retroperitoneal sarcoma
- Pregnant or breastfeeding
- Chemotherapy within 4 weeks prior to entering study
- Receiving other investigational agents
- Other types of sarcomas
- Multifocal disease, lymph node or distant metastases
See the full eligibility criteria
- Histologically proven primary soft tissue sarcoma of the retroperitoneum
- Measurable disease
- Life expectancy of greater than 2 years
- Prior radiation therapy for retroperitoneal sarcoma
- Pregnant or breastfeeding
- Chemotherapy within 4 weeks prior to entering study
- Receiving other investigational agents
- Other types of sarcomas
- Multifocal disease, lymph node or distant metastases
- History of sensitivity to radiation therapy
- Uncontrolled intercurrent illness
- History of a different invasive malignancy within the past 3 years
- HIV positive on combination anti-retroviral therapy
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
- Boston, Massachusetts, United States
- Rochester, Minnesota, United States
- Creve Coeur, Missouri, United States
- St Louis, Missouri, United States
- Buffalo, New York, United States
- Durham, North Carolina, United States
- Houston, Texas, United States
- Salt Lake City, Utah, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States; Boston, Massachusetts, United States; Rochester, Minnesota, United States; Creve Coeur, Missouri, United States; St Louis, Missouri, United States; Buffalo, New York, United States and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.